Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Population Pharmacokinetics and Pharmacodynamics of Thiotepa and TEPA in Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT).

NCT03609840 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT03609840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03609840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Population Pharmacokinetics and Pharmacodynamics of Thiotepa and TEPA in Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT).
Lead sponsor
University of California, San Francisco
Phase
Observational
Overall status
Completed
Start date
May 24, 2017
Completion date
July 31, 2023
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fanconi anemia, genetic inborn errors of metabolism, hematologic malignancies, hemoglobinopathies, immune deficiency, nonmalignant diseases, sickle cell disease, thalassemia